New York Post Ozempic, Wegovy prices to drop up to 50% as Novo Nordisk’s rivalry with Eli Lilly heats up: report
Drugmaker Novo Nordisk plans to slash list prices for its wildly popular weight-loss and diabetes drugs Wegovy and Ozempic by as much as 50%, according to a report.